EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that Stephen J. Farr, President and CEO, will provide a corporate update at the 8th Annual SVB Leerink Global Healthcare Conference, being held February 27-March 1, 2019, in New York, NY.
Zogenix Presentation Details
| Date: | Wednesday, February 27, 2019 |
| Time: | 9:00 AM Eastern Time / 6:00 AM Pacific Time |
| Location: | New York, NY - Lotte New York Palace Hotel |
The presentation will be webcast live and archived for 90 days on Zogenix's Investor Relations website at https://zogenixinc.gcs-web.com.
About Zogenix
Zogenix is a global pharmaceutical company committed to developing and commercializing transformative therapies to improve the lives of patients and their families living with rare diseases. For more information, visit www.zogenix.com.
CONTACT:
Zogenix
Melinda Baker
Senior Director, Corporate Communications
media@zogenix.com
Media
Rachel Lipsitz
Public Relations, Syneos Health
+1 (858) 449 9575 | rachel.lipsitz@syneoshealth.com
Investors
Andrew McDonald
Founding Partner, LifeSci Advisors LLC
+1 (646) 597-6987 | Andrew@lifesciadvisors.com